rs121909035
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_000492.4(CFTR):c.2845C>T(p.His949Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00000342 in 1,461,710 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.2845C>T | p.His949Tyr | missense_variant | Exon 17 of 27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251372Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135850
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461710Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727158
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cystic fibrosis Pathogenic:1
- -
not specified Uncertain:1
Variant summary: CFTR c.2845C>T (p.His949Tyr) results in a conservative amino acid change located in the transmembrane domain (IPR011527) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251372 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.2845C>T has been reported in the literature as a non-informative genotype in presumed compound heterozygosity with a different variant of uncertain significance in an individual affected with disseminated bronchiectasis (Ghanem_1994 cited in Girodon_1997) and more has recently been reported to segregate with congenital unilateral absence of vase deferens (CUAVD) in a consanguineous Iranian family where it was observed as a compound heterozygous genotype with other variants whose pathogenicity has not been unequivocally established (namely p.Leu997Phe and p.Ile148Thr) (Ghouchanatigh_2022). The basis for pathogenicity prediction in this study was a predictive software program and the reported phenotype of CUAVD is not considered as informative for a CFTR-related disorder therefore has not been weighted in our ascertainment. Several publications report experimental evidence evaluating an impact on protein function, characterizing the variant as a partially processing-defective mutant that prolongs the duration of the channel open state and reduces bicarbonate (but not chloride) transport to 50-65% of wild-type activity (e.g., Seibert_1996, Chen_2000, Choi_2001). The exact in-vivo impact of these findings remains equivocal. The following publications have been ascertained in the context of this evaluation (PMID: 10736180, 11242048, 7522211, 34755701, 9272738, 8910333). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at